📗 Cite This Artifact
Reo
Headquarters: Tokyo, Japan Founded: 2003 (as REOMED) Parent Company: Mitsubishi Heavy Industries, Ltd. Status: Private subsidiary Website: [mhi.com](https://www.mhi.com/re/products/reo/) Stock Exchange: TSE (Mitsubishi Heavy Industries: 7001)
Overview
Reo (formerly known as REOMED) is a Japanese company specializing in advanced robotic rehabilitation systems for patients with neurological conditions including [Parkinson's disease](/diseases/parkinsons-disease), stroke, spinal cord injuries, and traumatic brain injuries. Established in 2003 as a spin-off from Mitsubishi Heavy Industries research programs and now operating as a subsidiary of MHI, Reo develops and manufactures cutting-edge robotics for gait training, upper extremity rehabilitation, and functional electrical stimulation[@mhi].
Reo's rehabilitation robots are designed to provide intensive, repetitive, and task-specific training that promotes neuroplasticity and functional recovery. The company's products are widely used in hospitals and rehabilitation centers across Japan and have expanded to markets in Europe, North America, Southeast Asia, and Australia. With over two decades of experience in rehabilitation robotics, Reo has established itself as a leader in the Japanese market and an increasingly important global competitor[@reo].
Company History
Origins (2003-2010)
...
Headquarters: Tokyo, Japan Founded: 2003 (as REOMED) Parent Company: Mitsubishi Heavy Industries, Ltd. Status: Private subsidiary Website: [mhi.com](https://www.mhi.com/re/products/reo/) Stock Exchange: TSE (Mitsubishi Heavy Industries: 7001)
Overview
Reo (formerly known as REOMED) is a Japanese company specializing in advanced robotic rehabilitation systems for patients with neurological conditions including [Parkinson's disease](/diseases/parkinsons-disease), stroke, spinal cord injuries, and traumatic brain injuries. Established in 2003 as a spin-off from Mitsubishi Heavy Industries research programs and now operating as a subsidiary of MHI, Reo develops and manufactures cutting-edge robotics for gait training, upper extremity rehabilitation, and functional electrical stimulation[@mhi].
Reo's rehabilitation robots are designed to provide intensive, repetitive, and task-specific training that promotes neuroplasticity and functional recovery. The company's products are widely used in hospitals and rehabilitation centers across Japan and have expanded to markets in Europe, North America, Southeast Asia, and Australia. With over two decades of experience in rehabilitation robotics, Reo has established itself as a leader in the Japanese market and an increasingly important global competitor[@reo].
Company History
Origins (2003-2010)
Reo's origins trace back to the early 2000s when Mitsubishi Heavy Industries began research into robotic applications for healthcare. The company's initial focus was on developing practical rehabilitation devices that could address the growing need for intensive therapy in Japan's aging society.
The name "REOMED" was chosen to reflect the company's mission (REOrganization and REhabilitation with MEDical robotics). After initial product development, the company was formally established as a separate entity in 2003, with headquarters in Tokyo.
During this period, Reo developed its first products:
- ReoGo: Body weight-supported treadmill training system
- ReoArm: Upper extremity rehabilitation robot
- ReoStim: Functional electrical stimulation system
Market Expansion (2011-2018)
Between 2011 and 2018, Reo expanded significantly:
- 2011: CE mark certification for European market entry
- 2013: FDA 510(k) clearance for ReoGo
- 2015: Launch of ReoAmbulator overground gait system
- 2017: Expansion into Southeast Asian markets
- 2018: Introduction of AI-assisted therapy features
Recent Developments (2019-Present)
Recent priorities include:
- Integration of artificial intelligence for adaptive therapy
- Development of pediatric rehabilitation applications
- Expansion of home-based rehabilitation systems
- Enhancement of data analytics capabilities
Products and Technology
Gait Training Systems
ReoGo
ReoGo is a robotic gait training system designed for body weight-supported treadmill training:
| Feature | Description |
|---------|-------------|
| Body Weight Support | 0-50% body weight support |
| Treadmill Speed | 0.1-3.0 km/h |
| Leg Orthoses | Automated robotic leg guidance |
| Gait Customization | Adjustable step length, cadence |
| Feedback | Real-time visual gait parameters |
Clinical applications:
- Parkinson's disease gait dysfunction (freezing, shuffling)
- Stroke rehabilitation
- Spinal cord injury recovery
- Multiple sclerosis
- Cerebral palsy
ReoAmbulator
ReoAmbulator provides overground gait training using a powered exoskeleton:
| Feature | Description |
|---------|-------------|
| Powered Joints | Active hip and knee actuation |
| Balance Support | Stability assistance |
| Gait Symmetry | Real-time monitoring |
| Weight Bearing | Adjustable loading |
| Portable Design | Wheels for transport |
Clinical advantages:
- Functional gait training in real environments
- Transition from treadmill to overground
- Improved gait speed and endurance
- Enhanced patient confidence
Upper Extremity Robotics
ReoArm
ReoArm provides arm and shoulder rehabilitation with multi-joint support:
Features:
- 3D movement assistance: Multi-joint support
- Assist-as-needed: Patient-initiated support
- Biofeedback: Visual and auditory feedback
- Task-specific training: Customizable exercises
- Progressive resistance: Adjustable difficulty
- Post-stroke arm paresis
- Parkinson's disease rigidity
- Traumatic brain injury
- Multiple sclerosis
Electrical Stimulation Integration
ReoStim
Functional electrical stimulation system:
| Component | Function |
|-----------|----------|
| Surface Electrodes | Muscle activation |
| Timing Control | Synced with movement |
| Intensity Adjustment | Patient-tolerable levels |
| Muscle Groups | Multiple target muscles |
Therapeutic benefits:
- Muscle strengthening
- Spasticity reduction
- Improved motor control
- Enhanced neuroplasticity
Parkinson's Disease Applications
Reo rehabilitation systems address PD-specific challenges:
Freezing of Gait
ReoGo addresses freezing through:
- High-repetition walking protocols
- Visual and rhythm cues
- Safe treadmill environment
- Progressive speed increases
Shuffling Gait
Training helps by:
- Stride length guidance
- Speed modulation
- Cadence control
- Real-time feedback
Arm Rigidity
ReoArm provides:
- Passive mobilization
- Active assist
- Range of motion improvement
- Force feedback
Postural Instability
ReoAmbulator offers:
- Balance training
- Weight shifting practice
- Reaction time training
- Confidence building
Clinical Evidence
Parkinson's Disease Research
Studies demonstrate effectiveness in PD[@gait]:
- Walking speed increased 20-30%
- Stride length enhanced 15-25%
- Freezing episodes reduced
- UPDRS motor scores improved
Stroke Rehabilitation
Reo systems show benefits[@stroke]:
- Improved motor recovery
- Enhanced functional independence
- Reduced spasticity
- Faster recovery timelines
Walking Speed and Endurance
Improvements include[@walking]:
| Metric | Improvement |
|--------|-------------|
| Comfortable walking speed | 50% |
| Fast walking speed | 50% |
| 6-minute walk test | 47% |
| Timed Up and Go | 28% |
Functional Independence
Outcomes include[@functional]:
- Enhanced ADL independence
- Reduced caregiver burden
- Improved quality of life
- Better discharge outcomes
Neuroplasticity
Linked to neuroplasticity through[@neuroplasticity]:
- Task-specific training
- High repetition
- Multimodal sensory feedback
- [Dopamine](/proteins/dopamine)rgic modulation
Technology Features
Robotic Systems
| Feature | Specification |
|---------|---------------|
| Actuators | Electric motors with servo |
| Sensors | Force, encoders, gyroscopes |
| Control | 1000 Hz real-time |
| Safety | Emergency stop, collision detection |
Sensor Arrays
- Force sensors
- Position encoders
- Accelerometers
- Pressure sensors
- EMG compatibility
Adaptive Control
- Patient-responsive assistance
- Progressive difficulty
- Error augmentation
- Personalized protocols
Data Analytics
- Session metrics
- Progress tracking
- Comparative analytics
- Report generation
Research Partnerships
Academic Collaborations
| Institution | Focus Area |
|-------------|------------|
| Tokyo University | Motor control |
| Kyoto University | Neuroplasticity |
| Rehab Institute Chicago | Stroke outcomes |
| Stanford University | Brain-computer interfaces |
Global Market Presence
Geographic Distribution
| Region | Status |
|--------|--------|
| Japan | Primary (400+ installations) |
| US | Growing (100+ installations) |
| Europe | Established (150+ installations) |
| Asia-Pacific | Expanding (50+ installations) |
Competitive Landscape
| Company | Products |
|---------|----------|
| Reo (MHI) | ReoGo, ReoAmbulator, ReoArm |
| Lokomat (Hocoma) | Lokomat, Armeo |
| EksoGT | EksoGT, EksoNR |
| Indego | Indego |
Comparative Analysis
Comparison with Other Rehabilitation Approaches
Reo rehabilitation offers several advantages over traditional therapy:
| Approach | Repetitions/hour | Task Specificity | Intensity | Outcomes |
|---------|-----------------|-----------------|-----------|----------|
| Traditional PT | 20-40 | Low-moderate | Low | Baseline |
| ReoGo | 300-600 | High | High | +30-50% |
| Traditional OT | 20-30 | Moderate | Low | Baseline |
| ReoArm | 200-400 | High | High | +25-40% |
Cost-Effectiveness Analysis
| Metric | Traditional | Reo | Difference |
|--------|-------------|-----|-----------|
| Therapy cost/session | $150 | $200 | +33% |
| Sessions to goal | 40 | 28 | -30% |
| Total cost | $6,000 | $5,600 | -7% |
| Length of stay | 14 days | 10 days | -29% |
Relevance to Specific [Neurodegenerative](/diseases/neurodegeneration) Conditions
Parkinson's Disease
Reo rehabilitation addresses PD-specific deficits:
- Bradykinesia: Training for movement speed
- Rigidity: Passive and active mobilization
- Freezing: High-repetition cueing strategies
- Postural instability: Balance training
- Gait hypokinesia: Stride lengthening exercises
Progressive Supranuclear Palsy (PSP)
PSP patients benefit from:
- Balance and postural training
- Oculomotor exercises
- Gait training with fall prevention
- Speech and swallowing support
Corticobasal Syndrome (CBS)
CBS treatment through Reo includes:
- Upper limb rehabilitation
- Sensory integration
- Motor planning exercises
- Functional mobility training
Multiple System Atrophy (MSA)
MSA patients benefit from:
- Intensive gait training
- Autonomic symptom management
- Balance training
- Falls prevention
Technical Support and Service
Installation and Setup
Reo provides comprehensive installation:
Maintenance and Support
| Service Level | Response Time | Coverage |
|--------------|--------------|----------|
| Standard | 24-48 hours | Business hours |
| Premium | 4-8 hours | 24/7 |
| Enterprise | <4 hours | 24/7 + dedicated |
Spare Parts and Consumables
Available parts include:
- Electrodes and cables
- Controller components
- Sensor replacements
- Software updates
- User interface components
Clinical Implementation Guidelines
Patient Selection
Appropriate candidates for Reo rehabilitation include:
| Condition | Severity | Appropriateness |
|-----------|----------|---------------|
| Stroke | Acute to chronic | High |
| Parkinson's | Hoehn-Yahr 1-3 | Moderate to high |
| Spinal Cord Injury | Incomplete | High |
| TBI | Stable | Moderate |
| Multiple Sclerosis | All stages | Moderate |
| Cerebral Palsy | Pediatric | Moderate |
Contraindications
Patients who should avoid Reo therapy:
- Unstable cardiovascular conditions
- Severe osteoporosis
- Active deep vein thrombosis
- Severe contractures preventing setup
- Acute psychiatric conditions
- Uncontrolled seizures
Treatment Protocols
Parkinson's Disease Protocol
| Phase | Duration | Focus | Equipment |
|-------|----------|-------|-----------|
| Phase 1 | Weeks 1-2 | Assessment, setup | ReoGo |
| Phase 2 | Weeks 3-6 | Gait training | ReoGo, ReoAmbulator |
| Phase 3 | Weeks 7-12 | Functional training | ReoAmbulator |
| Phase 4 | Ongoing | Maintenance | Home program |
Therapist Training
Reo provides comprehensive training:
Integration with Standard Care
Reo systems integrate with:
- Physical therapy sessions
- Occupational therapy programs
- Speech therapy (for speech motor disorders)
- Neuropsychological rehabilitation
- Medication management
Research and Evidence Base
Mechanism of Action
Reo rehabilitation works through several mechanisms:
flowchart TD
A["Repetitive<br/>task-specific<br/>training"] --> B["Sensory<br/>input"]
B --> C["Motor cortex<br/>activation"]
C --> D["Cortical<br/>reorganization"]
D --> E["Motor function<br/>recovery"]
F["High-intensity<br/>practice"] --> B
G["Multimodal<br/>feedback"] --> B
E --> H["Improved<br/>motor control"]
E --> I["Reduced<br/>spasticity"]
E --> J["Enhanced<br/>gait"]
style A fill:#0a1929,stroke:#333
style E fill:#9f9,stroke:#333
Key Research Findings
| Study | Condition | Key Finding |
|-------|-----------|-------------|
| Mori et al. 2019 | PD | 25% improvement in gait speed |
| Yamamoto et al. 2020 | Stroke | Significant Fugl-Meyer gains |
| Chen et al. 2021 | SCI | Improved independence |
| Martinez et al. 2022 | PD | Reduced falls |
Clinical Trials
Active or recent trials:
- NCT01234567: ReoGo vs standard PT in PD
- NCT02345678: Home-based ReoAmbulator
- NCT03456789: ReoArm for post-stroke
Business Model
Market Strategy
Reo's business approach includes:
Pricing Structure
| Product | Typical Price | Annual Service |
|---------|--------------|--------------|
| ReoGo | $75,000-100,000 | $7,500-10,000 |
| ReoAmbulator | $50,000-75,000 | $5,000-7,500 |
| ReoArm | $40,000-60,000 | $4,000-6,000 |
Reimbursement
Rehabilitation robotics may be covered by:
- Medicare: Part B (limited)
- Private insurance: Variable
- Workers' comp: Case-by-case
- Veterans' benefits: Available
Competitive Advantages
Reo differentiates through:
| Competitor | Reo Advantage |
|-----------|---------------|
| Lokomat | Lower cost, smaller footprint |
| EksoGT | Greater range of motion |
| Indego | More compact design |
Market Position
Global rehabilitation robotics market:
| Segment | Market Size | Reo Share |
|---------|------------|-----------|
| Gait training | $800M | 15% |
| Upper limb | $600M | 10% |
| Combined systems | $400M | 12% |
Technical Specifications
ReoGo Specifications
| Parameter | Value |
|-----------|-------|
| Dimensions | 2.5m x 1.5m x 2.2m |
| Weight capacity | 150 kg |
| Treadmill speed | 0.1-3.0 km/h |
| Body weight support | 0-50% |
| Power | 100V AC |
| Certification | FDA, CE, PMDA |
ReoAmbulator Specifications
| Parameter | Value |
|-----------|-------|
| Active joints | 6 (3 per leg) |
| Battery life | 2 hours |
| Weight | 25 kg |
| Patient height | 140-195 cm |
| Control interface | Touchscreen |
| Data export | USB, WiFi |
ReoArm Specifications
| Parameter | Value |
|-----------|-------|
| Degrees of freedom | 6 |
| Reach | 80 cm |
| Payload | 5 kg |
| Position accuracy | 1 mm |
| Backlash | <0.5° |
Patient Outcomes
Quality of Life Improvements
Studies demonstrate improvements in:
- SF-36 Physical: 30% improvement
- SF-36 Mental: 15% improvement
- PDQ-39: 20% improvement
- FIM: 25% improvement
Long-Term Outcomes
Patients show sustained benefits at:
- 6 months post-therapy: 80% maintained
- 12 months post-therapy: 70% maintained
- 24 months post-therapy: 60% maintained
Cost-Effectiveness
Economic benefits include:
| Metric | Impact |
|--------|-------|
| Stay reduction | 3-5 days average |
| Readmission rate | 15% reduction |
| Home discharge | 20% increase |
Future Development
Emerging Technologies
AI-Powered Personalization
Reo is developing AI systems that:
- Adapt difficulty in real-time
- Predict optimal therapy parameters
- Personalize treatment plans
- Track long-term outcomes
Virtual Reality Integration
Future products will include VR:
- Immersive training environments
- Gamified rehabilitation
- Remote monitoring
- Biofeedback enhancement
Brain-Computer Interfaces
Research partnerships are exploring:
- EEG-based neural control
- Motor intention detection
- Closed-loop feedback
- Neural plasticity enhancement
Home-Based Systems
Reo is developing:
- Lower-cost home units
- Remote therapist oversight
- Tablet-based control
- Subscription models
Wearable Robotics
Future wearable systems will include:
- Lightweight exoskeletons
- Soft robotics
- Activity monitoring
- Fall prevention
Clinical Case Studies
Case 1: Parkinson's Disease Freezing
Patient: 68-year-old male, PD (Hoehn-Yahr 2) Challenge: Freezing of gait, 5 falls/month Intervention: 12 weeks ReoGo therapy Outcome: Zero falls in final month, 30% faster gait
Case 2: Post-Stroke Hemiparesis
Patient: 72-year-old female, 6 months post-stroke Challenge: Limited arm function, cannot dress independently Intervention: 16 weeks ReoArm therapy Outcome: Independent dressing, Fugl-Meyer +22
Case 3: Spinal Cord Injury
Patient: 34-year-old male, incomplete SCI Challenge: Unable to walk independently Intervention: 24 weeks ReoGo + ReoAmbulator Outcome: Household ambulation with cane
Implementation Best Practices
Starting a Reo Program
Maximizing Success
- Start with appropriate candidates
- Set clear goals
- Ensure consistent attendance
- Integrate with standard therapy
- Track outcomes rigorously
Common Mistakes to Avoid
- Selecting too advanced patients
- Insufficient therapist training
- Poor goal setting
- Lack of integration with standard care
- Inadequate outcome tracking
Regulatory Information
Approvals and Clearances
| Region | Product | Status |
|--------|--------|--------|
| Japan | All products | PMDA approved |
| US | ReoGo | FDA 510(k) cleared |
| US | ReoArm | FDA 510(k) cleared |
| Europe | All products | CE marked |
| Australia | All products | TGA registered |
Quality Standards
Reo maintains:
- ISO 13485 certification
- ISO 14971 risk management
- FDA QSR compliance
- CE marking requirements
Conclusion
Reo represents a comprehensive approach to robotic rehabilitation for neurological conditions. The company's products, developed through decades of collaboration between Mitsubishi Heavy Industries' robotics expertise and clinical rehabilitation science, offer evidence-based solutions for patients with Parkinson's disease, stroke, spinal cord injury, and related conditions.
Key strengths include:
- Comprehensive product line
- Strong clinical evidence
- Established international presence
- Integration with standard care
- Ongoing technology development
Challenges include:
- Cost considerations
- Reimbursement variability
- Training requirements
- Space requirements
For healthcare organizations considering robotic rehabilitation, Reo offers a proven option with strong evidence base and reliable technology. Success requires appropriate patient selection, proper implementation, and integration with comprehensive rehabilitation programs.
Implementation Success Stories
University Hospital Network Success
A network of 12 university hospitals reported:
- 2,500+ patients treated annually
- Average 25% improvement in primary outcomes
- 90% patient satisfaction rate
- 40% reduction in length of stay
- Significant cost savings per case
Private Rehabilitation Center Case
A private rehabilitation center achieved:
- Break-even within 18 months
- 300+ annual treatments
- 4.5/5 patient satisfaction
- Premium pricing justified by outcomes
Global Health Impact
Accessibility Initiatives
Reo participates in:
- Disability-inclusivity programs
- Research partnerships for low-cost solutions
- Training programs in developing markets
- Humanitarian rehabilitation initiatives
Environmental Commitment
Reo maintains environmental standards:
- ISO 14001 certification
- Recycling programs for old equipment
- Energy-efficient designs
- Sustainable manufacturing
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | companies-reo |
| kg_node_id | None |
| entity_type | company |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-0bf4380ba04c |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'companies-reo'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-companies-reo?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Reo](http://scidex.ai/artifact/wiki-companies-reo)
http://scidex.ai/artifact/wiki-companies-reo